| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/06/2010 | EP2139491A1 Use of glucocorticoids for treatment of congestive heart failure |
| 01/06/2010 | EP2139490A2 Diazo bicyclic smac mimetics and the uses thereof |
| 01/06/2010 | EP2139489A2 Mineralocorticoid receptor modulators |
| 01/06/2010 | EP2139488A1 Use of riboflavin in the treatment of hypertension |
| 01/06/2010 | EP2139485A2 Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring |
| 01/06/2010 | EP2139482A1 Treatment for multiple myeloma |
| 01/06/2010 | EP2139481A1 1-ý(2'-substituted)-piperazin-1'-yl¨-isoquinolines as norepinephrine transporter inhibitor therapeutics and positron emission tomography imaging agents |
| 01/06/2010 | EP2139480A1 Ranolazine for enhancing insulin secretion |
| 01/06/2010 | EP2139479A2 4-[2-(4-methylphenylsulfanyl)phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of adhd, melancholia, treatment resistent depression or residual symptoms in depression |
| 01/06/2010 | EP2139478A1 Certain chemical entities, compositions and methods |
| 01/06/2010 | EP2139474A2 Transcription factor modulating compounds and methods of use thereof |
| 01/06/2010 | EP2139473A1 Valsartan tablet formulations |
| 01/06/2010 | EP2139472A1 Tetrahydroindole derivatives as nadph oxidase inhibitors |
| 01/06/2010 | EP2139471A2 Treatment of age-related macular degeneration using inhibitors of complement factor d |
| 01/06/2010 | EP2139470A2 Gamma radiation sterilized nanoparticulate docetaxel compositions and methods for making the same |
| 01/06/2010 | EP2139469A2 Cobalamin taxane bioconjugates |
| 01/06/2010 | EP2139467A2 Neuroprotection in demyelinating diseases |
| 01/06/2010 | EP2139466A2 Magnesium compositions and uses thereof |
| 01/06/2010 | EP2139465A1 Composition comprising s-allylmercapto-n-acetylcysteine (assnac) for up-regulation of cellular glutathione level |
| 01/06/2010 | EP2139463A2 Anti-infective agents |
| 01/06/2010 | EP2139462A2 Calcimimetic compounds for use in the treatment of bowel disorders |
| 01/06/2010 | EP2139461A2 Amino derivatives to prevent nephrotoxicity and cancer |
| 01/06/2010 | EP2139460A1 Compositions and methods for the diagnosis, treatment, and prevention of amyotrophic lateral sclerosis and related neurological diseases |
| 01/06/2010 | EP2139455A2 A tablet having improved stability with at least two actives |
| 01/06/2010 | EP2139454A1 Non-ionizable hydrophobic galenical system |
| 01/06/2010 | EP2139453A1 Polyaphron topical composition with vitamin d |
| 01/06/2010 | EP2139337A1 Inhibitors of fibroblast activation protein, and methods of use thereof |
| 01/06/2010 | EP2139334A1 2-cyanophenyl fused heterocyclic compounds, and compositions and uses thereof |
| 01/06/2010 | EP2139333A1 Substituted pyrido[3,2-e][1,2,4]triazolo[4,3-c]pyrimidine derivatives as cannabinoid-1 receptor modulators |
| 01/06/2010 | EP2139332A1 Substituted pyrido[2,3-d]pyrimidine derivatives as cannabinoid-1 receptor modulators |
| 01/06/2010 | EP2139331A1 Compositions and methods relating to novel compounds and targets thereof |
| 01/06/2010 | EP2139330A1 Methods involving aldose reductase inhibitors |
| 01/06/2010 | EP2139329A1 Novel imidazo based heterocycles |
| 01/06/2010 | EP2139328A2 Hexahydro-cycloheptapyrazole cannabinoid modulators |
| 01/06/2010 | EP2139327A1 Method for treating cb2 receptor mediated pain |
| 01/06/2010 | EP2139326A1 Method for treating cb2 receptor mediated pain |
| 01/06/2010 | EP2139325A2 Anti-angiogenic agents and methods of use |
| 01/06/2010 | EP2139323A1 Treatment of gaucher disease with specific pharmacological chaperones and monitoring treatment using surrogate markers |
| 01/06/2010 | EP2139322A1 Indole carboxamides as ikk2 inhibitors |
| 01/06/2010 | EP2139320A1 Methods and compositions of derivatives of probucol for the treatment of diabetes |
| 01/06/2010 | EP2139319A2 Methods and compositions related to riboswitches that control alternative splicing |
| 01/06/2010 | EP2079711B1 2-phenyl-6-aminocarbonyl-pyrimidine derivatives and their use as p2y12 receptor antagonists |
| 01/06/2010 | EP2056820B1 A pharmaceutical composition for the treatment of a fungal skin disorder and a method for the preparation thereof |
| 01/06/2010 | EP2038275B1 Novel pyridazine compound and use thereof |
| 01/06/2010 | EP1957490B1 Novel indolizine derivatives, method for preparing same and therapeutic compositions comprising same |
| 01/06/2010 | EP1891029B1 Organic compounds for the treatment of imflammatory or alleric conditions |
| 01/06/2010 | EP1885364B1 Halogenated quindoline dimers for the treatment of cancer |
| 01/06/2010 | EP1773338B1 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 01/06/2010 | EP1742624B1 Dopamine-agonist combination therapy with sedatives for improving sleep quality |
| 01/06/2010 | EP1735278B1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 01/06/2010 | EP1687015B1 Compositions for the treatment of diseases of the oral cavity and upper respiratory tract |
| 01/06/2010 | EP1653974B1 Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for topical or other local application |
| 01/06/2010 | EP1635835B1 2-aminopyrimidine derivatives as raf kinase inhibitors |
| 01/06/2010 | EP1603597B1 Oxycodone conjugates with lower abuse potential and extended duration of action |
| 01/06/2010 | EP1575938B1 Compounds having selective inhibiting effect at gsk3 |
| 01/06/2010 | EP1562911B1 Compositions useful as inhibitors of jak and other protein kinases |
| 01/06/2010 | EP1558611B1 Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use |
| 01/06/2010 | EP1558265B1 Use of drospirenone for the treatment of hypertension |
| 01/06/2010 | EP1513831B1 Novel compounds, their use and preparation |
| 01/06/2010 | EP1489078B1 Benzofuran derivative |
| 01/06/2010 | EP1461073B1 Peptide agonists of prostate-specific antigen, and uses therefor |
| 01/06/2010 | EP1427713B1 Benzothiazepine derivatives for the treatment of hyperlipidemia |
| 01/06/2010 | EP1339414B1 L-histidine in ophthalmic solutions |
| 01/06/2010 | EP1062948B1 Remedies for non cardiogenic diastolic dysfunction |
| 01/06/2010 | EP1005361B1 USE OF FVIIa OR FVIIai FOR THE TREATMENT OF ENDOTHELIAL DYSFUNKTION AND FOR THE INHIBITION OF ANGIOGENESIS RESPECTIVELY |
| 01/06/2010 | EP0963197B1 Guanylhydrazones useful for treating diseases associated with t cell activation |
| 01/06/2010 | EP0934281B1 1-phenyl-benzimidazole compounds and their use as baga- a? receptor modulators |
| 01/06/2010 | CN201375684Y Simvastatin and nicotinic-acid double release capsule |
| 01/06/2010 | CN101622004A Imidated biopolymer adhesive and hydrogel |
| 01/06/2010 | CN101622003A Therapeutic agent for ameliorating prognosis after lower limb amputation surgery |
| 01/06/2010 | CN101622002A Compounds and uses thereof |
| 01/06/2010 | CN101622001A Purine compounds and compositions as kinase inhibitors for the treatment of plasmodium related diseases |
| 01/06/2010 | CN101622000A Process for the synthesis of glyt-1 inhibitors |
| 01/06/2010 | CN101621999A Medicinal composition for transdermal absorption, medicinal composition storing unit and transdermal absorption preparation using the same |
| 01/06/2010 | CN101621998A Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group |
| 01/06/2010 | CN101621997A Pharmaceutical composition |
| 01/06/2010 | CN101621996A Cosmetic oral and/or parenteral use of glucosamine optionally in combination with at least one polyphenol compound, and corresponding composition |
| 01/06/2010 | CN101621995A Mineralcorticoid receptor antagonists for the treatment of endometriosis |
| 01/06/2010 | CN101619057A N-substituted piperidine derivatives as serotonin receptor agents |
| 01/06/2010 | CN101618045A Anti-adhesion gel containing polyhydroxyalkanoate |
| 01/06/2010 | CN101618044A Capsule containing ginseng saponin, radix notoginseng saponin and amino acids and preparation method thereof |
| 01/06/2010 | CN101618043A Use of 1,2,3,4,6-penta-O-galloyl-b-D-glucose in preparation of anti-flu drugs |
| 01/06/2010 | CN101618042A Medicament for treating herpes and neurodermatitis |
| 01/06/2010 | CN101618041A Application of chromane compound HEF-04 in relaxing blood vessel smooth muscle |
| 01/06/2010 | CN101618040A Use of cetirizine for preparing medicine for treating perianalpruritus or perineum pruritus |
| 01/06/2010 | CN101618039A Pneumonia treatment |
| 01/06/2010 | CN101618038A Treatment of antibiotic-resistant bacteria infection |
| 01/06/2010 | CN101618037A Application of syn-1-methyl-1, 2, 3a, 4, 8b-hexahydropyrrole[3, 2f]azaindene |
| 01/06/2010 | CN101618036A Novel medicinal application of carboxyl aminotriazole and acceptable salts of the carboxyl aminotriazole |
| 01/06/2010 | CN101618035A Application of indirubin in preparing medicine for treating influenza virus infection |
| 01/06/2010 | CN101618034A Capsule with effect of weight reducing and preparation technology thereof |
| 01/06/2010 | CN101618033A New medical application of chromane compound HEF-05 |
| 01/06/2010 | CN101618032A Application of sodium houttuyfonate in preparing medicament for preventing and treating myocardial hypertrophy and/or ventricular hypertrophy |
| 01/06/2010 | CN101618031A New application of sesquiterpene medicine |
| 01/06/2010 | CN100578227C TTK in diagnosis and as a therapeutic target in cancer |
| 01/06/2010 | CN100577790C Methods for the production of 3-O-deactivated-4'-monophosphoryl lipid A(3D-MLA) |
| 01/06/2010 | CN100577728C Finely particulate composite containing carbon compound encapsulated therein |
| 01/06/2010 | CN100577681C Compounds, compositions and methods for treatment of inflammatory diseases and conditions |
| 01/06/2010 | CN100577678C Macrolide analogue drug double sidechain illotycin A derivative, synthesis method and uses |
| 01/06/2010 | CN100577677C Caulis trachelospermi total lignans extractive, extraction method and medicine use of the active constituent thereof |